Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Quinolone Antibiotic Market by Type (Ciprofloxacin, Levofloxacin, Gatifloxacin, Moxifloxacin, Ofloxacin, Norfloxacin, Others), By Application (Hospital, Clinics, Research, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Quinolone Antibiotic Market by Type (Ciprofloxacin, Levofloxacin, Gatifloxacin, Moxifloxacin, Ofloxacin, Norfloxacin, Others), By Application (Hospital, Clinics, Research, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 286873 4200 Pharma & Healthcare 377 216 Pages 4.9 (49)
                                          

Market Overview:


The global quinolone antibiotic market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing incidence of infectious diseases, rising demand for quinolone antibiotics from hospitals and clinics, and growing research and development activities for new quinolone antibiotics. However, the high cost of these drugs is likely to restrain the growth of this market during the forecast period. On the basis of type, ciprofloxacin accounted for a major share of the global quinolone antibiotic market in 2017. This segment is expected to maintain its dominance during the forecast period due to its high efficacy against various types of infections caused by bacteria.


Global Quinolone Antibiotic Industry Outlook


Product Definition:


A quinolone antibiotic is a type of antibiotic that belongs to the family of drugs called fluoroquinolones. These antibiotics are used to treat a variety of infections, including respiratory tract infections, skin infections, and urinary tract infections.


Ciprofloxacin:


Ciprofloxacin, also known as Flixabi, is an antibiotic drug and a quinolone. It is used for the treatment of bacterial infections including pneumonia. The drug has been approved by the U.S Food and Drug Administration (FDA) for the treatment of ventilator-associated pneumonia (VAP), community-acquired pneumonia (CAP), acute bacterial skin infection, and urinary tract infection in women who are pregnant or breastfeeding.


Levofloxacin:


Levofloxacin is a quinolone antibiotic which is used in the treatment of bacterial infections. It works by killing the bacteria, mainly because it belongs to the class of drugs called fluoroquinolones. Levofloxacin has a broad spectrum of antimicrobial activity and can be used against various types of bacteria such as E.


Application Insights:


The hospital application segment led the market and accounted for more than 60.0% share of the global revenue in 2017. The rising prevalence of multidrug-resistant bacteria is expected to drive demand for quinolone antibiotics in hospital applications, thereby driving growth over the forecast period. In addition, increasing healthcare spending as a result of growing population coupled with rising disposable income levels in developing countries such as China and India is expected to augment demand over the forecast period.


The clinics application segment was valued at USD 544 million in 2017 owing to high usage rates and sales volumes recorded by this sector during recent years due to an increase in infections caused by drug-resistant bacteria among other factors such as low immunity levels among patients due to unhealthy lifestyle habits and improper medical care which are likely to contribute towards industry growth during future periods.


Regional Analysis:


Asia Pacific dominated the global quinolone antibiotic market in 2017 and is expected to witness the fastest growth over the forecast period. This can be attributed to increasing livestock farming, which has led to an increase in animal infections leading to high demand for antibiotics. In addition, rising healthcare expenditure coupled with growing patient awareness levels regarding treatment options is anticipated fuel regional growth during the forecast period.


The Asia Pacific region comprises emerging economies such as China and India that are also among top exporters of agricultural commodities globally. The presence of a large population base suffering from chronic diseases such as cardiovascular disorders, diabetes, and cancer have resulted in increased consumption of these drugs within this region; hence driving their production capacity along with high demand for new drugs within this region will further boost industry expansion over next eight years  time frame.


Growth Factors:


  • Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the key growth drivers for the quinolone antibiotic market. Quinolones are effective against a wide range of bacteria, including both Gram-positive and Gram-negative organisms. This makes them an important tool in the treatment arsenal against infections caused by multi-drug resistant bacteria.
  • Rising demand for targeted therapies: Quinolones are also increasingly being used as targeted therapies, owing to their ability to selectively inhibit bacterial DNA replication. This has led to their growing adoption in the treatment of various serious infections, such as pneumonia, urinary tract infection (UTI), and sepsis.
  • Growing R&D investments: The quinolone antibiotic market is witnessing significant R&D investments from pharmaceutical companies, with a focus on developing novel drugs with improved efficacy and safety profiles. For instance, Johnson & Johnson’s Janssen Pharmaceuticals unit has recently announced its plans to develop a new generation of quinolones that could overcome resistance issues associated with currently available drugs in this class.

Scope Of The Report

Report Attributes

Report Details

Report Title

Quinolone Antibiotic Market Research Report

By Type

Ciprofloxacin, Levofloxacin, Gatifloxacin, Moxifloxacin, Ofloxacin, Norfloxacin, Others

By Application

Hospital, Clinics, Research, Others

By Companies

Healthy Life Pharma, Mercury Medicare, Merck, Tianjin Glory Technology, Hebei Guangren Pharmaceutical Technology, Healthy Life Pharma

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

216

Number of Tables & Figures

152

Customization Available

Yes, the report can be customized as per your need.


Global Quinolone Antibiotic Market Report Segments:

The global Quinolone Antibiotic market is segmented on the basis of:

Types

Ciprofloxacin, Levofloxacin, Gatifloxacin, Moxifloxacin, Ofloxacin, Norfloxacin, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Clinics, Research, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Healthy Life Pharma
  2. Mercury Medicare
  3. Merck
  4. Tianjin Glory Technology
  5. Hebei Guangren Pharmaceutical Technology
  6. Healthy Life Pharma

Global Quinolone Antibiotic Market Overview


Highlights of The Quinolone Antibiotic Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Ciprofloxacin
    2. Levofloxacin
    3. Gatifloxacin
    4. Moxifloxacin
    5. Ofloxacin
    6. Norfloxacin
    7. Others
  1. By Application:

    1. Hospital
    2. Clinics
    3. Research
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Quinolone Antibiotic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Quinolone Antibiotic Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Quinolone antibiotics are a type of antibiotic that is used to treat infections. Quinolones work by killing the bacteria cells that are causing the infection.

Some of the key players operating in the quinolone antibiotic market are Healthy Life Pharma, Mercury Medicare, Merck, Tianjin Glory Technology, Hebei Guangren Pharmaceutical Technology, Healthy Life Pharma.

The quinolone antibiotic market is expected to register a CAGR of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Quinolone Antibiotic Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Quinolone Antibiotic Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Quinolone Antibiotic Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Quinolone Antibiotic Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Quinolone Antibiotic Market Size & Forecast, 2018-2028       4.5.1 Quinolone Antibiotic Market Size and Y-o-Y Growth       4.5.2 Quinolone Antibiotic Market Absolute $ Opportunity

Chapter 5 Global Quinolone Antibiotic Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Quinolone Antibiotic Market Size Forecast by Type
      5.2.1 Ciprofloxacin
      5.2.2 Levofloxacin
      5.2.3 Gatifloxacin
      5.2.4 Moxifloxacin
      5.2.5 Ofloxacin
      5.2.6 Norfloxacin
      5.2.7 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Quinolone Antibiotic Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Quinolone Antibiotic Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Clinics
      6.2.3 Research
      6.2.4 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Quinolone Antibiotic Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Quinolone Antibiotic Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Quinolone Antibiotic Analysis and Forecast
   9.1 Introduction
   9.2 North America Quinolone Antibiotic Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Quinolone Antibiotic Market Size Forecast by Type
      9.6.1 Ciprofloxacin
      9.6.2 Levofloxacin
      9.6.3 Gatifloxacin
      9.6.4 Moxifloxacin
      9.6.5 Ofloxacin
      9.6.6 Norfloxacin
      9.6.7 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Quinolone Antibiotic Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Clinics
      9.10.3 Research
      9.10.4 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Quinolone Antibiotic Analysis and Forecast
   10.1 Introduction
   10.2 Europe Quinolone Antibiotic Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Quinolone Antibiotic Market Size Forecast by Type
      10.6.1 Ciprofloxacin
      10.6.2 Levofloxacin
      10.6.3 Gatifloxacin
      10.6.4 Moxifloxacin
      10.6.5 Ofloxacin
      10.6.6 Norfloxacin
      10.6.7 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Quinolone Antibiotic Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Clinics
      10.10.3 Research
      10.10.4 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Quinolone Antibiotic Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Quinolone Antibiotic Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Quinolone Antibiotic Market Size Forecast by Type
      11.6.1 Ciprofloxacin
      11.6.2 Levofloxacin
      11.6.3 Gatifloxacin
      11.6.4 Moxifloxacin
      11.6.5 Ofloxacin
      11.6.6 Norfloxacin
      11.6.7 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Quinolone Antibiotic Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Clinics
      11.10.3 Research
      11.10.4 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Quinolone Antibiotic Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Quinolone Antibiotic Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Quinolone Antibiotic Market Size Forecast by Type
      12.6.1 Ciprofloxacin
      12.6.2 Levofloxacin
      12.6.3 Gatifloxacin
      12.6.4 Moxifloxacin
      12.6.5 Ofloxacin
      12.6.6 Norfloxacin
      12.6.7 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Quinolone Antibiotic Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Clinics
      12.10.3 Research
      12.10.4 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Quinolone Antibiotic Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Quinolone Antibiotic Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Quinolone Antibiotic Market Size Forecast by Type
      13.6.1 Ciprofloxacin
      13.6.2 Levofloxacin
      13.6.3 Gatifloxacin
      13.6.4 Moxifloxacin
      13.6.5 Ofloxacin
      13.6.6 Norfloxacin
      13.6.7 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Quinolone Antibiotic Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Clinics
      13.10.3 Research
      13.10.4 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Quinolone Antibiotic Market: Competitive Dashboard
   14.2 Global Quinolone Antibiotic Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Healthy Life Pharma
      14.3.2 Mercury Medicare
      14.3.3 Merck
      14.3.4 Tianjin Glory Technology
      14.3.5 Hebei Guangren Pharmaceutical Technology
      14.3.6 Healthy Life Pharma

Our Trusted Clients

Contact Us